Navigation Links
Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011
Date:9/27/2011

Media have less than three weeks to register for Europe's largest cancer congress: The 2011 European Multidisciplinary Cancer Congress in Stockholm, 23-27 September 2011. To register, go to: www.ecco-org.eu

The 2011 European Multidisciplinary Cancer Congress will take place at the Stockholmsmssan (Stockholm International Fairs), Stockholm, Sweden, (www.stofair.se) from Friday 23 September to Tuesday 27 September 2011.

There will be over 2,000 presentations and around 16,000 participants from 120 countries, making it the largest European cancer congress to date. It is the only cancer congress in Europe to offer presentations of cutting-edge research across the whole cancer field, and will include basic and translational research, first reports from high quality phase II and III clinical trials, epidemiology and much more. In addition, for the first time there will be five new tracks, including industry and "oncotechnology". The "oncopolicy" track launched at the 2009 congress will continue to tackle issues of prime importance to the European cancer community, as well as helping to inform European policy and ensuring cancer's place at the top of the EU health and research policy agenda.

There will be media news briefings at the following times:
Friday 23 September: 13.00 hrs CEST Swedish language news briefing for local journalists
Friday 23 September: 17.00 hrs CEST Opening press conference
Saturday 24 September: 08.00 hrs CEST
Sunday 25 September: 08.00 hrs CEST
Monday 26 September: 08.00 hrs CEST
Monday 26 September: 11.15 hrs CEST

With the exception of the first press conference in Swedish for the local journalists, all other press conferences will be in English.

Here is a sample of some of the news to be announced at the congress (all information is embargoed):

  • Is there a relationship between high blood pressure and the risk of developing or dying from cancer?
  • New way of delivering treatment directly to the liver delivers extra months of disease-free life for melanoma patients
  • Giving chemotherapy to pregnant women: what is the effect on their children?
  • One size may not fit all: regular checks needed through the course of cancer to determine changes in tumour make-up and identify appropriate treatment
  • New treatment can delay the onset of bone metastases in prostate cancer
  • Results from two new Phase III trials reveal new ways of relieving pain from bone metastases in prostate cancer patients, and of improving their overall survival
  • Results from phase III international trial shows significant benefits in quality of life for prostate cancer patients treated with new drug
  • New drug combination can delay breast cancer progression in patients with advanced disease
  • Potentially practice-changing results of major UK trial combining radiotherapy with chemotherapy in women with early breast cancer
  • Latest update from the BIG 1-98 trial on the use of letrozole in post-menopausal women with early breast cancer
  • Could smaller, faster trials improve patient survival by making new drugs available more quickly?
  • Radical changes needed to develop equitable, affordable cancer care for all
  • Standardising clinical practice across Europe: treatment of rectal cancer varies enormously between different countries
  • Researchers discover gene that is mutated in some blood cancers and predicts better survival
  • Two new, cost-effective ways to predict prostate cancer
  • Elderly breast cancer patients are at risk of treatment discrimination
  • Results from phase III trial of everolimus combined with exemestane: new hope for post-menopausal women with advanced breast cancer resistant to hormone therapy
  • Does zoledronic acid added to standard adjuvant therapy reduce risk of recurrence in breast cancer patients?

Opening times for the congress press office in Stockholm and telephone numbers:
Friday 23 September 09.00 19.00 hrs (CEST)
Saturday 24 Monday 26 September 07.30 18.00 hrs
Tuesday 27 September 08.00 14.00 hrs

Tel: +46 (0)8 727 2107, +46 (0)8 727 2108 or +46 (0)8 727 2109
Fax: +46 (0)8 727 2138
Press officers: Emma Mason, Mary Rice, Kay Roche, Saffina Rana, Lisa Lnner Pulkkinen

The majority of the abstracts will be published online at 12.00 hrs CEST on Monday 12 September and can be reported from this time. You can find them at: http://stockholm2011.ecco-org.eu/programmesearch

However, any abstracts that are in the official media programme or that are late-breaking or "best" abstracts will not be published online until the day of presentation at the congress and are embargoed until that day.


'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Related medicine news :

1. Acoustical Society meeting: Highlights and media registration
2. Media advisory: 2011 AAPS Annual Meeting and Exposition
3. Inflammatory mediator enhances plaque formation in Alzheimer’s disease
4. Media registration opens for 2011 ASTRO Annual Meeting
5. Mayo Clinic finds social media valuable tool to recruit study participants for rare diseases
6. Telephone trumps social media when communicating with teens about research
7. International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia
8. Studies examine impact of media use among youth, recommend preventative measures
9. Study of phytoremediation benefits of 86 indoor plants published
10. News media registration opens for American Chemical Society National Meeting
11. Immediate use of an IUD following abortion more likely to prevent unintended pregnancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... ... SunView Software’s Service Smart Technology has been selected as a finalist for ... year, Pink Elephant recognizes a new product or service developed by an IT services ... opportunity. The award highlights original innovations that were released in 2016, either as a ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... at the National Association of Music Merchants (NAMM) winter trade show, Booth #2876, ... , Etymotic’s ER•4® has long been the gold standard for high-definition, in-ear earphones. ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... as well as Palm Desert, is opening a new office in San Clemente, ... transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling with major ...
(Date:1/17/2017)... ... 17, 2017 , ... Medic-CE , a Career Step ... has released four new continuing education courses as part of its Code3 CME ... online classroom and meet the requirements of the National Continued Competency Program (NCCP), ...
(Date:1/17/2017)... ... 17, 2017 , ... Surgeons from New York’s fastest growing ... on the latest breakthroughs in the prevention, diagnosis and treatment of the most ... eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD and Managing ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017   Seno Medical Instruments, Inc. ... breast cancer through the development of an opto-acoustic (OA/US) ... Miller as SVP of Engineering. Mr. Miller previously ... FUJIFILM SonoSite, with headquarters in Bothell, Washington ... his 30-year career to the development of innovative medical ...
(Date:1/18/2017)... Jan. 18, 2017  Tarix Orphan LLC today announced ... a Rare Pediatric Disease (RPD) designation for the company,s ... Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. There ... is limited to supportive care. "The RPD ... Designation previously granted by the FDA in this indication," ...
(Date:1/18/2017)... January 18, 2017 After the recent ... the use of cannabis both for medical and recreational purposes ... Americans open to the use of cannabis, but the focus ... to Arcview Market Research, the North American legal cannabis market ... the previous year. The research projects sales will grow at ...
Breaking Medicine Technology: